Germany's Merck, Siemens Team Up to Accelerate AI Drug Discovery
By Billy Gray
Germany's Merck KGaA and Siemens signed an agreement to speed up the deployment of artificial intelligence to discover and develop new drugs.
Merck, a chemicals and life-sciences company, and industrial conglomerate Siemens said Tuesday that the deal extends an existing partnership between them. The pair of German companies will seek to deliver digital workflows integrating software solutions, automation, data and AI that will boost medical innovation from drug discovery through manufacturing, they said.
The collaboration will focus on bridging gaps in drug research and biomanufacturing with the goal of therapies moving faster from the lab to patients, the companies said.
Pilot projects include integrating Merck's AI capabilities and the applications available in Luma, a scientific intelligence platform Siemens gained with its $5.1 billion acquisition of Dotmatics earlier this year.
Write to Billy Gray at william.gray@wsj.com
(END) Dow Jones Newswires
September 23, 2025 04:02 ET (08:02 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States